Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

NCT06005792 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Psoriasis
Atopic Dermatitis

Interventions

BIOLOGICAL: XmAb27564
BIOLOGICAL: Placebo

Sponsor

Xencor, Inc.